S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%
A daily business newspaper · Founded in 2026

Money Talk

Finance and markets: business, quotes, gold, energy and releases.

Jury Rules Arm Breached Licensing Agreement with Qualcomm

A federal jury has concluded that Arm violated its long-standing Architectural License Agreement with Qualcomm, marking a significant legal setback for the chip designer. The verdict validates Qualcomm’s claims that Arm failed to uphold its contractual commitments and deliberately sought to disrupt the company’s business operations.

Jury Rules Arm Breached Licensing Agreement with Qualcomm
Photo: Bio & News

The ruling adds to a series of legal victories for Qualcomm, reinforcing their position in an escalating dispute over semiconductor technology rights. Qualcomm executives described the decision as a win for innovation and competitive fairness, noting that the jury’s findings expose broader efforts by Arm to undermine the Qualcomm ecosystem. Despite the ongoing litigation, Qualcomm confirmed its commitment to advancing its product roadmap, specifically highlighting the development of its Oryon CPU line.

This legal friction stems from the complex licensing ties between the two entities, which remain critical to the global mobile and computing markets. By securing this verdict, Qualcomm effectively fends off attempts to restrict its access to foundational architectural designs. The company continues to prioritize the delivery of its semiconductor hardware to consumers worldwide while maintaining its stance against what it characterizes as anticompetitive behavior from its partner-turned-adversary.

Share article
TelegramXFacebook

When reusing this material a link to Money Talk is required.

Comments (0)

Leave a comment

No comments yet. Be the first!